Drug intelligence / Profile preview

Protella

Development stage: Unknown
Lead developer: Emblazon Life Sciences
Modality: Small Molecules, Peptides
Administration: Oral

Overview

Protella is a nutritional supplement marketed by Emblazon Life Sciences, an Indian pharmaceutical company based in Pune. It is part of the company's Aura brand, which focuses on women's health and wellness. Protella is typically formulated as a protein powder enriched with essential vitamins, minerals, and often includes docosahexaenoic acid (DHA) and gamma-linolenic acid (GLA). It is primarily indicated for use during pregnancy and lactation to support maternal health and fetal development, as well as for general nutritional support in patients recovering from illness or surgery.

Brand names: Protella
Other names: Protella-Emblaze

Beyond the preview

Go deeper on Protella.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protella.

Explore the full profile